Finance

Lists
HNSA:STO
Hansa Biopharma AB
46,84 SEK
+1,21%
(+0,56) 1D
13 ნოე, 17:29:56 GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
46,50 SEK
High
47,84 SEK
Low
42,74 SEK
Mkt. cap
4,77 მლრდ.
Avg. vol.
616,01 ათ.
Volume
0,00
52-wk high
49,32 SEK
52-wk low
23,52 SEK
EPS
-7,91 SEK
Shares outstanding
101,76 მლნ.
No. of employees
111
Open
46,50 SEK
High
47,84 SEK
Low
42,74 SEK
Mkt. cap
4,77 მლრდ.
Avg. vol.
616,01 ათ.
Volume
0,00
52-wk high
49,32 SEK
52-wk low
23,52 SEK
EPS
-7,91 SEK
Shares outstanding
101,76 მლნ.
No. of employees
111
News stories
From web sources and news partners
Barron's
Barron's
·
10 წუთის წინ
Amundi Core S&P 500 UCITS ETF Overview (SNP5)
AP News
AP News
·
1 დღის წინ
Microsoft outage shows the risks of relying on a single technology provider for essential services
Investor's Business Daily
Investor's Business Daily
·
3 საათის წინ
Futures Loom As Bitcoin Dives In Shaky Rally. What To Do Now.
Yahoo Finance
Yahoo Finance
·
18 საათის წინ
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
About Hansa Biopharma AB
CEOსორენ ტულსტრუპი
Employees111
Founded2007
Headquarters-
SectorHealth Care
Industry-
Websitehansabiopharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
75,99 მლნ.
34,57 მლნ.
48,10 მლნ.
142,99 მლნ.
Cost of goods sold
24,66 მლნ.
13,78 მლნ.
22,33 მლნ.
76,18 მლნ.
Cost of revenue
24,66 მლნ.
13,78 მლნ.
22,33 მლნ.
76,18 მლნ.
Research and development expenses
74,43 მლნ.
57,34 მლნ.
67,87 მლნ.
65,36 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101,62 მლნ.
105,56 მლნ.
118,93 მლნ.
147,55 მლნ.
Operating expense
176,02 მლნ.
162,90 მლნ.
186,83 მლნ.
205,39 მლნ.
Total operating expenses
200,67 მლნ.
176,68 მლნ.
209,16 მლნ.
281,57 მლნ.
Operating income
-124,68 მლნ.
-142,11 მლნ.
-161,06 მლნ.
-138,58 მლნ.
Other non operating income
-
1,38 მლნ.
-30,53 მლნ.
31,20 მლნ.
EBT including unusual items
-169,50 მლნ.
-195,87 მლნ.
-259,86 მლნ.
-177,85 მლნ.
EBT excluding unusual items
-169,50 მლნ.
-195,87 მლნ.
-259,86 მლნ.
-140,05 მლნ.
Income tax expense
396,00 ათ.
453,00 ათ.
677,00 ათ.
623,00 ათ.
Effective tax rate
-0,23%
-0,23%
-0,26%
-0,35%
Other operating expenses
-34,00 ათ.
-
28,00 ათ.
-7,52 მლნ.
Net income
-169,90 მლნ.
-196,32 მლნ.
-260,54 მლნ.
-178,48 მლნ.
Net profit margin
-223,58%
-567,89%
-541,71%
-124,82%
Earnings per share
-1,62
-1,93
-2,26
-1,63
Interest and investment income
-
2,55 მლნ.
3,20 მლნ.
-
Interest expense
-208,06 მლნ.
-28,90 მლნ.
-58,48 მლნ.
-32,66 მლნ.
Net interest expenses
-208,06 მლნ.
-26,35 მლნ.
-55,27 მლნ.
-32,66 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-124,05 მლნ.
-141,48 მლნ.
-149,39 მლნ.
-126,40 მლნ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები